Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J Donnelly

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Vaccine|April 3, 2016
Universal influenza vaccines: Shifting to better vaccinesFrancesco Berlanda Scorza, Vadim Tsvetnitsky, John J Donnelly
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
DNA vaccines: progress and challengesJohn J Donnelly, Britta Wahren, Margaret A Liu
Science (New York, N.Y.)|August 27, 2002
Envelope-based HIV vaccinesJohn J Donnelly, Susan W Barnett, Alejandro Dorenbaum, et al.
Human Vaccines & Immunotherapeutics|June 22, 2013
Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countriesKutub Mahmood, Sonia Pelkowski, Deborah Atherly, et al.
Microbes and Infection|November 9, 2005
Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and CSusan W Barnett, Indresh K Srivastava, Jeffrey B Ulmer, et al.
Journal of Virology|May 14, 2003
Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccinesJan zur Megede, Gillis R Otten, Barbara Doe, et al.
Transfusion|March 16, 2018
Report of a workshop on ensuring sustainable access to safe blood in developing countries: International Blood Safety Forum, March 24, 2017Louis M Katz, John J Donnelly, Christopher J Gresens, et al.
Cellular Immunology|December 4, 2003
Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticlesKimberly S Denis-Mize, Marc Dupuis, Manmohan Singh, et al.
Plos Currents|February 11, 2012
Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in micePhilip R Dormitzer, Rino Rappuoli, Daniele Casini, et al.
Journal of Virology|February 28, 2002
Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virusIndresh K Srivastava, Leonidas Stamatatos, Harold Legg, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Vaccine|April 3, 2016
Universal influenza vaccines: Shifting to better vaccinesFrancesco Berlanda Scorza, Vadim Tsvetnitsky, John J Donnelly
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2005
DNA vaccines: progress and challengesJohn J Donnelly, Britta Wahren, Margaret A Liu
Science (New York, N.Y.)|August 27, 2002
Envelope-based HIV vaccinesJohn J Donnelly, Susan W Barnett, Alejandro Dorenbaum, et al.
Human Vaccines & Immunotherapeutics|June 22, 2013
Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countriesKutub Mahmood, Sonia Pelkowski, Deborah Atherly, et al.
Microbes and Infection|November 9, 2005
Development of V2-deleted trimeric envelope vaccine candidates from human immunodeficiency virus type 1 (HIV-1) subtypes B and CSusan W Barnett, Indresh K Srivastava, Jeffrey B Ulmer, et al.
Journal of Virology|May 14, 2003
Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccinesJan zur Megede, Gillis R Otten, Barbara Doe, et al.
Transfusion|March 16, 2018
Report of a workshop on ensuring sustainable access to safe blood in developing countries: International Blood Safety Forum, March 24, 2017Louis M Katz, John J Donnelly, Christopher J Gresens, et al.
Cellular Immunology|December 4, 2003
Mechanisms of increased immunogenicity for DNA-based vaccines adsorbed onto cationic microparticlesKimberly S Denis-Mize, Marc Dupuis, Manmohan Singh, et al.
Plos Currents|February 11, 2012
Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in micePhilip R Dormitzer, Rino Rappuoli, Daniele Casini, et al.
Journal of Virology|February 28, 2002
Purification and characterization of oligomeric envelope glycoprotein from a primary R5 subtype B human immunodeficiency virusIndresh K Srivastava, Leonidas Stamatatos, Harold Legg, et al.
Pageof 3